INBS - Latest News

Intelligent Bio Solutions Inc. (INBS), operates in Healthcare / Medical - Devices, trades on NASDAQ.

Market capitalization stands near $1.5M. Beta to the broader market is 4.21.

The article list below shows the most recent INBS headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent INBS Headlines

BlackRock Inc. Invests $149.96 Million in Intelligent Bio Solutions Inc. $INBS

defenseworld.net - Aug 29, 2026

BlackRock Inc. purchased a new stake in shares of Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth of 38% Year-over-Year, Driven by Reader Installed Base and High-Margin Cartridge Growth

globenewswire.com - Aug 19, 2026

Reader installed base grew 22% year-over-year, driving a 35% increase in total consumable cartridges to over 100,000 units

Intelligent Bio Solutions Shares Surge Monday: What's Driving the Action?

benzinga.com - Aug 17, 2026

Shares of Intelligent Bio Solutions Inc. (NASDAQ:INBS) are surging Monday afternoon after the medical technology company announced a significant regu

Intelligent Bio Solutions Strengthens Quality Management Credentials with ISO Recertification

globenewswire.com - Aug 17, 2026

Recertification aligns with the FDA's newly amended Quality Management System Regulation and supports the Company's regulatory strategy as it pursues

Intelligent Bio Solutions Announces Completion of Method Comparison Study for the Intelligent Fingerprinting Drug Screening System

globenewswire.com - Aug 11, 2026

NEW YORK, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc.

How News Affects INBS Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track INBS's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked INBS news questions

What is the latest INBS news headline?

The most recent INBS headline (Aug 29, 2026) is "BlackRock Inc. Invests $149.96 Million in Intelligent Bio Solutions Inc. $INBS". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.

How fresh is the INBS news on this page?

News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.

What INBS news moves options pricing?

Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.

How can I track unusual INBS options activity related to news?

Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.